Over the two-year study period, patients receiving GLP-1based therapy experienced: Importantly, the study authors did not observe an increased risk for key diabetes-related complications, including diabetic ketoacidosis and hypoglycemia
If supplementing, 250 mg per day is considered a reasonable dose [14]
Reported symptoms include headache, nausea, diarrhea, facial flushing, and in rare cases, skin rash or tingling
Knockdown of GPX4 re-sensitized the resistant cells to ferroptosis inducers
doi: 10.1212/WNL.00000209275, Hack W et al
[31] Since L-carnitine has a central role in fat metabolism and has significant antioxidant properties as well, carnitine supplementation has been investigated as a treatment option in the management of type 2 diabetes